Obesity and Diet

Anti-Obesity drugs

The best anti-obesity medication would result in minimum adverse effects and long-term weight loss. Energy balance regulation mechanisms are highly redundant by design, have significant overlap with other physiological processes, and are impacted by social, hedonic, and psychological factors, which reduce the efficacy of pharmacological therapies. Drugs that target metabolic pathways in skeletal muscle, liver, and adipocytes have showed promise in preclinical research, but none have entered clinical development. Recent advances in knowledge of leptin and its upstream pathways in the hypothalamus, as well as peptidergic signaling of hunger and satiety from the gastrointestinal tract mediated by ghrelin, cholecystokinin, peptide YY, and glucagon-like peptide-1, have created new opportunities.